Compare · ISRG vs MYO
ISRG vs MYO
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Myomo Inc. (MYO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISRG and MYO operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $145.92B, about 2452.3x MYO ($59.5M).
- Over the past year, ISRG is down 21.1% and MYO is down 45.5% - ISRG leads by 24.4 points.
- MYO has been more active in the news (11 items in the past 4 weeks vs 10 for ISRG).
- ISRG has more recent analyst coverage (25 ratings vs 3 for MYO).
- Company
- Intuitive Surgical Inc.
- Myomo Inc.
- Price
- $411.98-3.43%
- $1.56+18.18%
- Market cap
- $145.92B
- $59.5M
- 1M return
- -1.90%
- +88.38%
- 1Y return
- -21.14%
- -45.55%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- AMEX
- IPO
- 2000
- 2017
- News (4w)
- 10
- 11
- Recent ratings
- 25
- 3
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Myomo Inc.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Latest ISRG
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $29,104 worth of shares (69 units at $421.80) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 1,454 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $169,656 worth of shares (400 units at $424.14) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 5,720 units (SEC Form 4)
- Chief Executive Officer (CEO) Rosa David J. converted options into 1,358 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 0.28% to 245,893 units (SEC Form 4) to cover taxes
- SVP & GM da Vinci Platforms & Jeddi Iman sold $2,365,594 worth of shares (5,625 units at $420.55) as part of a pre-agreed trading plan and exercised 5,625 shares at a strike of $77.00 (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $15,945 worth of shares (36 units at $442.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,523 units (SEC Form 4)
- SEC Form SD filed by Intuitive Surgical Inc.
- Intuitive Announces Innovations to Advance Quintuple Aim
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)
Latest MYO
- Chief Commercial Officer Mitchell Micah covered exercise/tax liability with 6,529 shares, decreasing direct ownership by 6% to 102,949 units (SEC Form 4)
- Chief Medical Officer Kovelman Harry covered exercise/tax liability with 7,635 shares, decreasing direct ownership by 7% to 100,983 units (SEC Form 4)
- Chief Financial Officer Henry David A covered exercise/tax liability with 10,050 shares, decreasing direct ownership by 2% to 435,124 units (SEC Form 4)
- Director Kirk Thomas F bought $50,803 worth of shares (40,002 units at $1.27), increasing direct ownership by 6% to 693,865 units (SEC Form 4)
- Amendment: Chief Commercial Officer Mitchell Micah sold $77,689 worth of shares (90,231 units at $0.86), decreasing direct ownership by 45% to 109,478 units (SEC Form 4)
- Director Kirk Thomas F bought $24,825 worth of shares (25,000 units at $0.99), increasing direct ownership by 4% to 653,863 units (SEC Form 4)
- Chief Medical Officer Kovelman Harry sold $32,239 worth of shares (32,000 units at $1.01), decreasing direct ownership by 23% to 108,618 units (SEC Form 4)
- SEC Form SD filed by Myomo Inc.
- Director Kirk Thomas F bought $68,243 worth of shares (75,006 units at $0.91), increasing direct ownership by 14% to 628,863 units (SEC Form 4)
- Director Manko Joseph M. Jr. bought $173,908 worth of MYO (201,197 units at $0.86) (SEC Form 4)